📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study (2009)

First Author: Ciceri F

Attributed to: Expansion of the GMP facility for Stem Cell Therapy at Imperial College funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(09)70074-9

PubMed Identifier: 19345145

Publication URI: http://europepmc.org/abstract/MED/19345145

Type: Journal Article/Review

Parent Publication: The Lancet Oncology

Issue: 5

ISSN: 1470-2045